Author: nick
[ad_1] From N.Y. trial court judge Lisa Headley in VDARE Found., Inc. v. N.Y. Times Co., decided July 20: In this action, the plaintiff asserts claims for defamation arising from four articles. The plaintiff is seeking $700,000 in actual damages with punitive damages and costs. First, in August 2019, the plaintiff alleges, inter alia, that the defendant, in a Times article “quoted the associate director of the Anti-Defamation League opining that while the term ‘kritarch’ has historically been used in a non-pejorative way to describe ‘rule by judges,’ more recently it has been ‘co-opted’ by extremists and taken on a…
[ad_1] As the war in Iran has reached its fifth month, progress fails to be made and opposition continues to mount. And while President Donald Trump certainly deserves his fair share of the blame, the playbook he’s using is in no way his own. Since the Cold War, the United States has become the preeminent world power, utilizing its heavily budgeted and expansive military to enforce its hegemony across the globe. During the later years of the 20th century especially, this has primarily taken the form of strategic bombing and overwhelming air power. From the Gulf War to Iran, US…
[ad_1] Smart, Affordable Energy Built Iowa. Voters Must Protect It [ad_2] Source link
[ad_1] My second essay for SCOTUSBlog calls on the Justices to hold regular press conferences. Here is a snippet: My proposal for holding press conferences is unconventional, but I think it would be a net positive. At regular intervals, different members of the Supreme Court would hold a televised press conference before the Supreme Court press corps, as well as members of alternative media outlets, such as podcasters. Certain topics would of course be off limits. The justices could not opine on any pending cases. They also could not offer any opinions that could trigger a recusal on some matter.…
[ad_1] Eli Lilly’s multibillion-dollar acquisition of a company that makes experimental psychedelic therapies marks the largest investment yet by a drugmaker in psychedelic medicine as a treatment for depression. But pharma’s entry into the market raises questions about patents, profits and the future of psychedelic therapy. Eli Lilly’s multibillion-dollar acquisition of AtaiBeckley marks the largest pharmaceutical investment yet in psychedelic medicine, signaling a new phase for an industry once relegated to the margins of scientific research. The deal, valued at approximately $2.8 billion upfront with up to $1 billion in additional milestone payments, gives Lilly control of AtaiBeckley’s experimental psychedelic therapies, including BPL-003, a fast-acting…
[ad_1] Now Comes the Hard Part for El-Sayed [ad_2] Source link
[ad_1] Instead of passing through bankruptcy, insolvent life insurers have all their liabilities-in particular the policyholder claims-paid for by state guaranty funds. [ad_2] Source link
[ad_1] I really don’t think we need to be debating the legitimacy of Thanksgiving right now. [ad_2] Source link
[ad_1] Are you worried about an AI market crash or a company going bankrupt? Don’t be. Just as with railroads 150 years ago, nothing can stop technological progress, writes Tyler Cowen. [ad_2] Source link
[ad_1] The divide between skeptics and believers often seems a gaping chasm, with personal ideology often trumping evidence for both groups. As long-time readers will know, here at the Grail we often champion inhabiting the ‘excluded middle’ – staying in a space where you can entertain strange ideas without becoming emotionally attached to them, and always testing them. So it was refreshing to hear the thoughts of Professor Jesse Bering when we interviewed him about his 2026 book delving into the life and work of one of the most well-known ‘heretical scientists’ of the past century, The Incredible Afterlives of…